Moral Agency and the Neuroscience of Addiction
Steve Hyman, M.D.
Steven E. Hyman, M.D. is Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology, director of the Stanley Center for Psychiatric Research, and a core faculty member at the Broad Institute of Harvard and MIT. From 2001 to 2011, he served as Provost of Harvard University, the University’s chief academic officer. From 1996 to 2001, he served as director of the US National Institute of Mental Health (NIMH), where he emphasized investment in neuroscience and emerging genetic technologies. He also initiated a series of large practical clinical trials, including an emphasis on children, a population about which little was known.
Hyman is member of the National Academy of Medicine (NAM) and the editor of the Annual Review of Neuroscience. He has served as President (2014-5) of the Society for Neuroscience, the leading professional organization for the field, is a Fellow and President-elect of the American College of Neuropsychopharmacology (ACNP), and was founding President of the International Neuroethics Society. Hyman serves on multiple nonprofit boards including the Dana Foundation and the Charles Revson Foundation, on the boards of two biotechnology companies, Voyager Therapeutics and Q State, and multiple scientific advisory boards. He is a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Association for the Advancement of Science, and a Distinguished Life Fellow of the American Psychiatric Association. Hyman received his B.A. summa cum laude from Yale College; an M.A. from the University of Cambridge, which he attended as a Mellon fellow; and an M.D. cum laude from Harvard Medical School.